Increased ALT and AST in obese individuals is usually a marker of NAFLD, an early stage of the liver disorder which can progress to nonalcoholic steatohepatitis (NASH) or even liver cirrhosis [15]. This evidence concerns the gene GPT and cirrhosis of liver.